| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Luo,Yun-Jun | Chairman | 5.91% | |
| Luo,Zhi-Li | Director | 4.93% | LIANG YAN INVESTMENT LTD. |
| Li,Qing-He | Director | 2.08% | |
| Chen,Jia-Jun | Director | 0.00% | |
| Chen,Li-Yun | Independent Director | 0.00% | |
| Ni,Zhi-Zhen | Independent Director | 0.00% | |
| Wei,Zhong-Jie | Independent Director | 0.00% |
Change Company Name to Sea Mild Biotechnology Co., Ltd
2023/08/21
Change Company Name to QINGJINGHAI BIOTECHNOLOGY CO., LTD. (FORMER NAME: QINGJINGHAI INTERNATIONAL CO., LTD.)
2022/06/10
Change Person in Charge to Luo,Yun-Jun
2022/06/10
Change Person in Charge to Li,Tai-Ping
2021/11/01
Change Person in Charge to Liu,Jie-Zhi
2021/04/29
Change Person in Charge to Lin,Shi-Long
2020/05/27
Change Capital to 500,000,000
2019/08/05
Change Capital to 300,000,000
2016/09/10
Change Capital to 200,000,000
2014/07/30
Change Person in Charge to Luo,Zhi-Li
2013/05/02
Change Capital to 150,000,000
2012/06/11
Change Company Name to Sea Mild Biotechnology Co., Ltd
2012/05/24
Change Capital to 100,000,000
2012/05/24
Change Capital to 75,000,000
2011/12/26
Change Person in Charge to Qiu,Qiu-Xiang
2011/10/14
Change Capital to 60,000,000
2011/09/29
下載完整報告查看完整數據
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Operating income | 135,974 | 257,018 | 202,649 |
| Operating cost | 97,195 | 200,647 | 166,494 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 38,779 | 56,371 | 36,155 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 38,779 | 56,371 | 36,155 |
| Operating expenses | 30,452 | 51,538 | 48,136 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 8,327 | 4,833 | -11,981 |
| Non-operating income and expenses | 7,474 | 1,299 | -9,502 |
| Net profit (loss) before tax | 15,801 | 6,132 | -21,483 |
| Income tax expense (benefits) | 0 | -55 | -103 |
| Net profit (loss) of ongoing business for the current period | 15,801 | 6,187 | -21,380 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 15,801 | 6,187 | -21,380 |
| Other comprehensive profit (loss), net | 0 | -265 | 45 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 15,801 | 5,922 | -21,335 |
| Net profit (loss) attributable to owners of parent company | 15,801 | 6,187 | -21,380 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 15,801 | 5,922 | -21,335 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | -1 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | -4,323 | 8,838 | 11,707 |
| Net cash inflows (outflows) from investing activities | -7,319 | -13,652 | -2,306 |
| Net cash inflow (outflow) from financing activities | 28,432 | 10,848 | -7,813 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0 | 16 | 45 |
| Increase (decrease) in cash and cash equivalents in the current period | 16,790 | 6,050 | 1,633 |
| Beginning balance of cash and cash equivalents | 46,628 | 40,578 | 38,945 |
| Ending balance of cash and cash equivalents | 63,418 | 46,628 | 40,578 |
| 項目 | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current asset | 195,945 | 150,838 | 123,392 |
| Non-current asset | 47,647 | 39,523 | 34,297 |
| Total asset | 243,592 | 190,361 | 157,689 |
| Current liability | 141,668 | 113,609 | 81,545 |
| Non-current liability | 15,718 | 6,347 | 11,661 |
| Total liability | 157,386 | 119,956 | 93,206 |
| share capital | 193,089 | 193,089 | 193,089 |
| Equity - secruity token | - | - | - |
| capital reserve | - | - | - |
| retained earning | -106,883 | -122,684 | -128,871 |
| Other equity | 0 | 0 | 265 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 86,206 | 70,405 | 64,483 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 86,206 | 70,405 | 64,483 |
| Share capital awaiting retirement (unit: share) | - | - | - |
| Issued shares of advance equity (unit: shares) | 0 | 0 | - |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | - |
| Net asset value per share | 4 | 3 | 3 |
